<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="0" ids="3098">Bile acid</z:chebi> toxicity has been shown in the gastric, colonic, and hepatic tissues; the effect on oesophageal mucosa is less well known </plain></SENT>
<SENT sid="1" pm="."><plain>AIMS: To determine the spectrum of <z:chebi fb="1" ids="3098">bile acids</z:chebi> refluxing in patients with <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> and its relation to oesophageal pH using a new technique of combined oesophageal <z:hpo ids='HP_0002835'>aspiration</z:hpo> and pH monitoring </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Ten asymptomatic subjects and 30 patients with symptoms of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> (minimal mucosal injury, <z:e sem="disease" ids="C0267055" disease_type="Disease or Syndrome" abbrv="">erosive oesophagitis</z:e> (grade 2 or 3 Savary-Miller), <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>/stricture; n=10 in each group) underwent 15 hour continuous oesophageal <z:hpo ids='HP_0002835'>aspiration</z:hpo> with simultaneous pH monitoring </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="3098">Bile acid</z:chebi> assay of the oesophageal samples was performed using modified high performance liquid chromatography </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The peak <z:chebi fb="0" ids="3098">bile acid</z:chebi> concentration and DeMeester acid scores were significantly higher in the patients with <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e> (median <z:chebi fb="0" ids="3098">bile acid</z:chebi> concentration 124 micromol/l; acid score 20.2) and <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>/stricture (181 micromol/l; 43 </plain></SENT>
<SENT sid="5" pm="."><plain>3) than patients with minimal injury (14 micromol/l; 12.5) or controls (0 micromol/l; 11.1) </plain></SENT>
<SENT sid="6" pm="."><plain>The predominant <z:chebi fb="1" ids="3098">bile acids</z:chebi> detected were cholic, taurocholic, and <z:chebi fb="0" ids="17687">glycocholic acids</z:chebi> but there was a significantly greater proportion of secondary <z:chebi fb="1" ids="3098">bile acids</z:chebi>, deoxycholic and <z:chebi fb="0" ids="9410">taurodeoxycholic acids</z:chebi>, in patients with <z:e sem="disease" ids="C0267055" disease_type="Disease or Syndrome" abbrv="">erosive oesophagitis</z:e> and <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>/stricture </plain></SENT>
<SENT sid="7" pm="."><plain>Although <z:chebi fb="0" ids="3098">bile acid</z:chebi> reflux episodes occurred at variable pH, a temporal relation existed between reflux of <z:chebi fb="5" ids="15891">taurine</z:chebi> conjugates and oesophageal acid exposure (r=0.58, p=0.009) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Toxic secondary <z:chebi fb="0" ids="3098">bile acid</z:chebi> fractions have been detected in patients with extensive mucosal damage </plain></SENT>
<SENT sid="9" pm="."><plain>Mixed reflux is more harmful than <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> alone with possible toxic synergism existing between the <z:chebi fb="5" ids="15891">taurine</z:chebi> conjugates and acid </plain></SENT>
</text></document>